Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Copeptin as a prognostic biomarker in acute myocardial infarction.
Lattuca B, Sy V, Nguyen LS, Bernard M, Zeitouni M, Overtchouk P, Yan Y, Hammoudi N, Ceccaldi A, Collet JP, Kerneis M, Diallo A, Montalescot G, Silvain J. Lattuca B, et al. Among authors: overtchouk p. Int J Cardiol. 2019 Jan 1;274:337-341. doi: 10.1016/j.ijcard.2018.09.022. Epub 2018 Sep 6. Int J Cardiol. 2019. PMID: 30217427
Periprocedural myocardial infarction and injury in elective coronary stenting.
Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, Barthelemy O, Hauguel-Moreau M, Choussat R, Helft G, Le Feuvre C, Collet JP, Montalescot G; ACTION Study Group. Zeitouni M, et al. Among authors: overtchouk p. Eur Heart J. 2018 Apr 1;39(13):1100-1109. doi: 10.1093/eurheartj/ehx799. Eur Heart J. 2018. PMID: 29365133
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin.
Silvain J, O'Connor SA, Yan Y, Kerneis M, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ankri A, Brugier D, Vicaut E, Ecollan P, Galier S, Collet JP, Montalescot G; ATOLL Investigators. Silvain J, et al. Among authors: overtchouk p. Am J Cardiovasc Drugs. 2018 Dec;18(6):503-511. doi: 10.1007/s40256-018-0294-z. Am J Cardiovasc Drugs. 2018. PMID: 30144017 Clinical Trial.
Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial.
Zeitouni M, Akin I, Desch S, Barthélémy O, Brugier D, Collet JP, de Waha-Thiele S, Greenwood JP, Guedeney P, Hage G, Hauguel-Moreau M, Huber K, Kerneis M, Noc M, Oldroyd KG, Piek JJ, Rouanet S, Savonitto S, Serpytis P, Silvain J, Stepinska J, Vicaut E, Vrints CJM, Windecker S, Zeymer U, Thiele H, Montalescot G; CULPRIT-SHOCK Trial Investigators. Zeitouni M, et al. Chest. 2021 Apr;159(4):1415-1425. doi: 10.1016/j.chest.2020.10.089. Epub 2020 Nov 26. Chest. 2021. PMID: 33248059
Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
Overtchouk P, Guedeney P, Rouanet S, Verhoye JP, Lefevre T, Van Belle E, Eltchaninoff H, Gilard M, Leprince P, Iung B, Barthelemy O, Le Breton H, Souteyrand G, Vicaut E, Montalescot G, Collet JP. Overtchouk P, et al. J Am Coll Cardiol. 2019 Jan 8;73(1):13-21. doi: 10.1016/j.jacc.2018.08.1045. Epub 2018 Aug 25. J Am Coll Cardiol. 2019. PMID: 30153483 Free article.
Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK Trial.
Zeitouni M, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Hage G, Overtchouk P, Brugier D, Vignolles N, Kerneis M, Silvain J, Collet JP, Vicaut E, Desch S, Zeymer U, Thiele H, Montalescot G. Zeitouni M, et al. Among authors: overtchouk p. Circ Cardiovasc Interv. 2019 Oct;12(10):e008296. doi: 10.1161/CIRCINTERVENTIONS.119.008296. Epub 2019 Oct 14. Circ Cardiovasc Interv. 2019. PMID: 31607157 Clinical Trial. No abstract available.
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
Guedeney P, Barthélémy O, Zeitouni M, Hauguel-Moreau M, Hage G, Kerneis M, Lattuca B, Overtchouk P, Rouanet S, Fuernau G, de Waha-Thiele S, Zeymer U, Sandri M, Akin I, Desch S, Thiele H, Montalescot G. Guedeney P, et al. Among authors: overtchouk p. JACC Cardiovasc Interv. 2020 May 25;13(10):1198-1206. doi: 10.1016/j.jcin.2020.04.003. JACC Cardiovasc Interv. 2020. PMID: 32438990 Free article. Clinical Trial.
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy.
Overtchouk P, Barthélémy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet JP, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G; Collaborators. Overtchouk P, et al. EuroIntervention. 2021 Feb 5;16(15):e1237-e1244. doi: 10.4244/EIJ-D-20-00139. EuroIntervention. 2021. PMID: 32624460 Free PMC article. Clinical Trial.
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
Braik N, Guedeney P, Behnes M, Desch S, Barthélémy O, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ouarrak T, Schneider S, Zeymer U, Thiele H, Montalescot G, Akin I. Braik N, et al. Among authors: overtchouk p. Am Heart J. 2021 Feb;232:185-193. doi: 10.1016/j.ahj.2020.11.009. Epub 2020 Nov 27. Am Heart J. 2021. PMID: 33253678 Clinical Trial.
44 results